Thorne HealthTech, Inc.
NASDAQ:THRN
10.19 (USD) • At close October 13, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Revenue
| 228.731 | 185.246 | 138.455 | 102.532 |
| Cost of Revenue
| 113.797 | 87.893 | 73.667 | 57.789 |
| Gross Profit
| 114.934 | 97.353 | 64.788 | 44.743 |
| Gross Profit Ratio
| 0.502 | 0.526 | 0.468 | 0.436 |
| Reseach & Development Expenses
| 7.424 | 5.936 | 4.225 | 3.899 |
| General & Administrative Expenses
| 75.586 | 54.913 | 0 | 0 |
| Selling & Marketing Expenses
| 26.443 | 25.189 | 0 | 0 |
| SG&A
| 102.029 | 80.103 | 59.548 | 54.751 |
| Other Expenses
| 1.343 | -0.088 | -0.244 | -0.254 |
| Operating Expenses
| 109.453 | 86.038 | 63.773 | 58.649 |
| Operating Income
| 5.481 | 9.752 | 0.771 | -13.906 |
| Operating Income Ratio
| 0.024 | 0.053 | 0.006 | -0.136 |
| Total Other Income Expenses Net
| 2.316 | 1.169 | -3.038 | -2.653 |
| Income Before Tax
| 7.797 | 10.921 | -2.267 | -16.559 |
| Income Before Tax Ratio
| 0.034 | 0.059 | -0.016 | -0.162 |
| Income Tax Expense
| -7.31 | 0.412 | 0.177 | 0.033 |
| Net Income
| 15.674 | 10.509 | -2.444 | -16.592 |
| Net Income Ratio
| 0.069 | 0.057 | -0.018 | -0.162 |
| EPS
| 0.3 | 0.33 | -0.048 | -0.46 |
| EPS Diluted
| 0.3 | 0.33 | -0.048 | -0.46 |
| EBITDA
| 10.305 | 15.68 | 5.066 | -9.562 |
| EBITDA Ratio
| 0.045 | 0.085 | 0.037 | -0.093 |